Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕Bank of India Business Cycle Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundBank of India Business Cycle Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataBank of India
NAV₹40.2296₹10.1100
NAV date20 Nov 202620 Nov 2026
History10.9 years2.2 years
Expense ratio1.1%1.4%
Stars★★★★★Not rated
Growth Score67.50—

Returns

Tata India Pharma & Healthcare FundBank of India Business Cycle Fund
1 month+9.87%+5.42%
3 months+1.12%+1.00%
6 months+7.63%+9.30%
YTD+13.73%+10.73%
1 year+11.82%+7.10%
3 years (CAGR)+18.74%—
5 years (CAGR)+16.00%—
10 years (CAGR)+15.95%—
Since launch+13.58%+0.40%

Risk

Tata India Pharma & Healthcare FundBank of India Business Cycle Fund
Volatility15.7%—
Downside volatility10.0%—
Sharpe0.78—
Sortino1.23—
Calmar1.12—
Return / risk1.19—
Deepest fall−19.84%−25.21%
Days to recover375—
Below its high+0.00%−3.44%

Against benchmark

Tata India Pharma & Healthcare FundBank of India Business Cycle Fund
Alpha−2.76%—
Beta1.00—
R²90.2%—
Up capture91.7%—
Down capture101.4%—
Tracking error4.9%—
Information ratio−0.57—
Treynor0.11—

Consistency

Tata India Pharma & Healthcare FundBank of India Business Cycle Fund
Best 1-year+76.35%+12.64%
Middle 1-year+8.85%+1.89%
Worst 1-year−17.32%−13.31%
1-year periods with a loss29.0%41.7%
Middle 3-year+21.13%—
Positive months63.9%—
Best day+3.34%+4.23%
Worst day−3.09%−3.87%
Worst 5% day−1.35%−1.77%
Positive days55.4%49.7%
NAVs a year247247

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundBank of India Business Cycle Fund
5-year XIRR+18.07%—
5-year value₹9,50,065—
3-year XIRR+13.31%—
1-year XIRR+18.41%+15.54%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth